 |
| Business and Market for TRTC Validated By Former FDA Executive Director Appointment |
|
 Hot Stock to Watch |
Company: Terra Tech Corp (OTCQB: TRTC)
|
Last:
Price: 0.19
Change (%): + 0.005 (2.70)
Volume: 367,063 |
 |
Terra Tech Corp taps Former Executive Director of the FDA for Advisory Board
(Irvine,CA) Terra Tech Corp (OTCBB:TRTC), a leader in sustainable agricultural products, is pleased to announce the appointment of Dr. Ronald Hart to the company’s Advisory Board.
Dr. Hart is an internationally recognized scientist, scholar and expert in business acceleration strategies for emerging growth companies. He is the former Chief Scientist and Executive Director of the FDA’s National Center for Toxicology Research and was the first person in the history of the FDA to be named “distinguished scientist in residence.” In addition, he was an author of the Federal Technology Transfer Act of 1986.
“Dr. Harts broad and accomplished background is a significant asset for our Terra Tech,” explains Derek A. Peterson, CEO of Terra Tech. “it’s rare you find someone who is both an academic and an operator, we are humbled to have his experienced guidance to help steer our company.”
Dr. Hart has received over two dozen national and international awards and recognitions for his scientific contributions, including the Karl August Forester Preis from the German Academy of Science and Literature, the Bose Medal from the Bose Institute of India, and appointments as Distinguished Professor at a number of institutes, including Cairo University and Guangzhou University.
“Companies like Terra Tech are helping find sustainable solutions to feeding our expanding global population.” Said Dr. Hart. “It is crucial our global society invest in these types of technologies in an effort to mitigate what could become a global food shortage in the coming decades.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
